Jon Akehurst
Director of Finance/CFO at HOTL CHOC
Profile
Jon Akehurst is currently the Chief Financial Officer & Executive Director at Hotel Chocolat Group Plc since 2023.
Prior to this, he worked as the Chief Financial Officer at Terumo Aortic Ltd.
from 2021 to 2023.
Jon Akehurst active positions
Companies | Position | Start |
---|---|---|
HOTL CHOC | Director of Finance/CFO | 2023-05-14 |
Former positions of Jon Akehurst
Companies | Position | End |
---|---|---|
Terumo Aortic Ltd.
Terumo Aortic Ltd. Medical SpecialtiesHealth Technology Part of Terumo Corp., Terumo Aortic Ltd. is a British company that delivers solutions to address each segment of the aorta and help restore function. The private company is based in Inchinnan, UK. The company provides support for vascular surgeons, cardiothoracic surgeons, and interventional radiologists in their efforts to deliver individualized solutions for each unique aorta. The CEOs are Brian Coll, Erik Pomp. The company was founded in 1921. | Director of Finance/CFO | 2023-04-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Hotel Chocolat Group Plc
Hotel Chocolat Group Plc Food: Specialty/CandyConsumer Non-Durables Hotel Chocolat Group Plc engages in the manufacture and retail of chocolate. Its products include boxed chocolates, wine and spirits, hot chocolate, cocoa cuisine, and gift collections through online and retail stores. The company was founded by Angus Thirlwell and Peter Mark Harris in 1993 and is headquartered in Royston, the United Kingdom. | Consumer Non-Durables |
Terumo Aortic Ltd.
Terumo Aortic Ltd. Medical SpecialtiesHealth Technology Part of Terumo Corp., Terumo Aortic Ltd. is a British company that delivers solutions to address each segment of the aorta and help restore function. The private company is based in Inchinnan, UK. The company provides support for vascular surgeons, cardiothoracic surgeons, and interventional radiologists in their efforts to deliver individualized solutions for each unique aorta. The CEOs are Brian Coll, Erik Pomp. The company was founded in 1921. | Health Technology |
- Stock Market
- Insiders
- Jon Akehurst